Skip to content
The Nexus
BUSINESSJun 4 · 05:45 UTCCNBC TOP

‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid

Biotech mergers and acquisitions in 2026 are experiencing a strong start, driven by patent cliffs, rising public market confidence, and pharmaceutical companies seeking to enhance their drug pipelines.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Biotech M&Atopicpatent cliffstopicpublic marketstopicBig Pharmaorganization
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting